The company reported that Acuvue Oasys Max 1-Day and Oasys 1-Day outperformed the other 5 daily disposable lenses evaluated in a recent study, among other Johnson & Johnson data highlights at AAOpt 2026.
|Videos|March 12, 2022
Augmenting corneal thickness with FDA-approved hypotonic riboflavin
Author(s)Alex Delaney-Gesing, Senior Editor
Daniel Fuller, OD, FAAO Dipl., FSLS, discusses augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin during SECO 2022.
Advertisement
Daniel Fuller, OD, FAAO Dipl., FSLS, discusses his SECO 2022 presentation "Augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin," with Optometry Times®' Alex Delaney-Gesing.
Advertisement
Related to this article
Three residents were honored for their leadership, education and research, and patient care contributions in ophthalmology, optometry, and retina.
American Academy of Optometry President Jeffrey Walline, OD, PhD, recommends attendees take advantage of the diverse array of educational and networking opportunities the conference offers.
Michael Cymbor, OD, FAAO, gives an overview of a rapid fire lecture he gave in collaboration with Andrew Rixon OD, FAAO; Austin Lifferth, OD, FAAO; and Derek MacDonald, OD, FAAO, at AAOpt 2026.
Clark Chang, OD, MSA, MSc, FAAO, discussed his presentation at AAOpt 2026 titled "A New Era in Corneal Surgery for Keratoconus."
Kaleb Abbott, OD, MS, FAAO, discusses the relationship between poor sleep, depression, anxiety, and dry eye.
David Webley, BSc (Hons), MCOptom, FBCLA, weighs in on SightGlass Vision's latest data presented at AAOpt's annual meeting in Anaheim, California.
An independent analysis of 600 patients across 20 US optometry offices found contact lens wearers generate 29% to 86% higher annual profits than eyeglasses-only patients.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2026: The human cost of dry eye
2
AAOpt 2026: How DOT lenses affect children’s everyday vision
3
Aldeyra to appeal FDA rejection of reproxalap as a treatment for dry eye disease
4
The Independent Advantage S02 E04: Lessons learned in AI implementation
5